PUMA BIOTECHNOLOGY, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $36.02 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-10
- PUMA BIOTECHNOLOGY, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $36.02M.
- PUMA BIOTECHNOLOGY, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $20.11M.
- PUMA BIOTECHNOLOGY, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.08M.
- PUMA BIOTECHNOLOGY, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $26.18M.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $36.02M 10-Q · filed 2018-05-10 | $56.12M derived: sum of 2 quarters · filed 2018-05-10 | $62.20M derived: sum of 3 quarters · filed 2018-05-10 | |
| 2017-12-31 | $20.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $26.18M derived: sum of 2 quarters · filed 2018-03-09 | $26.18M 10-K · filed 2018-03-09 | |
| 2017-09-30 | $6.08M 10-Q · filed 2017-11-09 | $6.08M 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |